Medtech
Haast Autonomous has raised US$1.85m in pre-seed funding to develop a medical drone system for moving sensitive supplies between healthcare sites. The Houston-based startup, named after the Dutch word for “haste”, pairs a custom aircraft with software that manages dispatch, routing and chain of custody. Chain of custody is the documented record of [...]
Joyvié has raised £771k to launch reusable incontinence underwear for people with faecal incontinence. The Sussex-based female-led startup has closed its pre-seed funding round through angel investment and Innovate UK grant funding. The money will support a direct-to-consumer product launch later in 2026. It will also fund clinical pilots across care home, hospital [...]
Alpha Tau Medical Ltd, developer of the innovative alpha-radiation cancer therapy Alpha DaRT, and Tolmar International Ltd., one of the strongest commercial players in the U.S. urology, oncology, endocrinology and paediatric endocrinology markets, have announced a strategic collaboration agreement to develop and commercialise Alpha DaRT for the treatment of prostate cancer in the United States. [...]
Emergency medical service SAMU de Paris has achieved an out-of-hospital cardiac arrest survival rate four times the global average, through a rescue therapy called ECPR. Previously largely confined to hospitals, deployment on Paris streets has been supported in part with the help of handheld ultrasound technology and AR glasses from international health tech company Mindray. [...]
Neurovalens has received FDA approval for its PTSD device, paving the way for the Northern Irish company to expand sales in the US. The Belfast group has secured De Novo approval from the US Food and Drug Administration for its technology designed to treat post-traumatic stress disorder. The system works by using low-level [...]
ReVision Implant has secured €4m in funding for its brain implant for severe blindness, as it moves from preclinical development towards first-in-human studies. The Belgian neurotechnology company said the oversubscribed funding round from private investors marks a key step in its transition from preclinical development to clinical exploration. The round included both existing investors and [...]
Phoenix Hospital Group has launched a new suite of Executive Health Assessments using Deep Resolve MRI technology, offering faster scan times and higher-resolution imaging for busy professionals seeking quicker access to preventative healthcare. The new service, launching at Phoenix Hospital Group in London’s prestigious Harley Street Health District, is part of ‘Phoenix Preventative Health’ which reflects growing demand for [...]
Boston Scientific Corporation has announced positive results from the pivotal FRACTURE Investigational Device Exemption (IDE) trial evaluating the use of the SEISMIQ 4CE Coronary Intravascular Lithotripsy Catheter to treat patients with severely calcified coronary artery disease (CAD). The study met its primary safety and effectiveness endpoints, demonstrating high rates of freedom from major adverse cardiac [...]
UroMems has raised US$60m from Ajax Health Fund I to support pivotal trials of its UroActive implant in the US and France ahead of regulatory submissions. The round is the company’s largest fundraising to date and comes less than a year after its US$47m Series C financing in June 2024. Co-founder Hamid Lamraoui [...]
Butterfly Medical, developer of a proprietary non-surgical solution for BPH (benign prostatic hyperplasia), today announced the successful completion of its Series C funding round, raising US$21 million. The strong institutional demand validates the company’s therapeutic approach and competitive positioning. The round includes participation from new and existing investors, including the European Innovation Council (EIC), Junson [...]
